1. Albert, P. R., Neve, K. A., Bunzow, J. R. and Civelli, O. (1990) Coupling of a cloned rat dopamine-D2 receptor to inhibition of adenylyl cyclase and prolactin secretion.
J Biol Chem, 265: 2098-2104.
[PMID:1688845]
2. Amenta, F., Chiandussi, L., Mancini, M., Ricci, A., Schena, M. and Veglio, F. (1994) Pharmacological characterization and autoradiographic localization of dopamine receptors in the human adrenal cortex.
Eur J Endocrinol, 131: 91-96.
[PMID:8038912]
3. Amenta, F., Collier, W. L. and Ricci, A. (1990) Autoradiographic localization of vascular dopamine receptors.
Am J Hypertens, 3: 34S-36S.
[PMID:2200435]
4. Amenta, F., Ricci, A. and Vega, J. A. (1990) Pharmacological characterization of rat renal medulla dopamine-sensitive cyclic adenosine monophosphate generating system.
J Pharmacol Exp Ther, 253: 246-249.
[PMID:2158544]
5. An, J. J., Bae, M. H., Cho, S. R., Lee, S. H., Choi, S. H., Lee, B. H., Shin, H. S., Kim, Y. N., Park, K. W., Borrelli, E. and Baik, J. H. (2004) Altered GABAergic neurotransmission in mice lacking dopamine D2 receptors.
Mol Cell Neurosci, 25: 732-741.
[PMID:15080900]
6. Araki, K., Kuwano, R., Morii, K., Hayashi, S., Minoshima, S., Shimizu, N., Katagiri, T., Usui, H., Kumanishi, T. and Takahashi, Y. (1992) Structure and expression of human and rat D2 dopamine receptor genes.
Neurochem Int, 21: 91-98.
[PMID:1363862]
7. Ariano, M. A., Stromski, C. J., Smyk-Randall, E. M. and Sibley, D. R. (1992) D2 dopamine receptor localization on striatonigral neurons.
Neurosci Lett, 144: 215-220.
[PMID:1436705]
8. Asa, S. L., Kelly, M. A., Grandy, D. K. and Low, M. J. (1999) Pituitary lactotroph adenomas develop after prolonged lactotroph hyperplasia in dopamine D2 receptor-deficient mice.
Endocrinology, 140: 5348-5355.
[PMID:10537166]
9. Baik, J. H., Picetti, R., Saiardi, A., Thiriet, G., Dierich, A., Depaulis, A., Le Meur, M. and Borrelli, E. (1995) Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors.
Nature, 377: 424-428.
[PMID:7566118]
10. Benoit-Marand, M., Borrelli, E. and Gonon, F. (2001) Inhibition of dopamine release via presynaptic D2 receptors: time course and functional characteristics in vivo.
J Neurosci, 21: 9134-9141.
[PMID:11717346]
11. Bertorello, A. and Aperia, A. (1990) Inhibition of proximal tubule Na(+)-K(+)-ATPase activity requires simultaneous activation of DA1 and DA2 receptors.
Am J Physiol, 259: F924-F928.
[PMID:1979719]
12. Bertorello, A. M., Hopfield, J. F., Aperia, A. and Greengard, P. (1990) Inhibition by dopamine of (Na(+)+K+)ATPase activity in neostriatal neurons through D1 and D2 dopamine receptor synergism.
Nature, 347: 386-388.
[PMID:1977083]
13. Boulay, D., Depoortere, R., Oblin, A., Sanger., D. J., Shoemaker, H. and Perrault, G. (2000) Haloperidol-induced catalepsy is absent in dopamine D2, but not in dopamine D3 receptor knock-out mice.
Eur. J. Pharmacol., 391: 63-73.
[PMID:10720636]
14. Boulay, D., Depoortere, R., Perrault, G., Borrelli, E. and Sanger, D. J. (1999) Dopamine D2 receptor knock-out mice are insensitive to the hypolocomotor and hypothermic effects of dopamine D2/D3 receptor agonists.
Neuropharmacology, 38: 1389-1396.
[PMID:10471093]
15. Breese, G. R., Duncan, G. E., Napier, T. C., Bondy, S. C., Iorio, L. C. and Mueller, R. A. (1987) 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
J Pharmacol Exp Ther, 240: 167-176.
[PMID:3100767]
16. Bughi, S., Jost-Vu, E., Antonipillai, I., Nadler, J. and Horton, R. (1994) Effect of dopamine2 blockade on renal function under varied sodium intake.
J Clin Endocrinol Metab, 78: 1079-1084.
[PMID:8175964]
17. Bunzow, J. R., Van Tol, H. H., Grandy, D. K., Albert, P., Salon, J., Christie, M., Machida, C. A., Neve, K. A. and Civelli, O. (1988) Cloning and expression of a rat D2 dopamine receptor cDNA.
Nature, 336: 783-787.
[PMID:2974511]
18. Burris, K. D., Pacheco, M. A., Filtz, T. M., Kung, M. P., Kung, H. F. and Molinoff, P. B. (1995) Lack of discrimination by agonists for D2 and D3 dopamine receptors.
Neuropsychopharmacology, 12: 335-345.
[PMID:7576010]
19. Cadet, J. L., Zhu, S. M. and Angulo, J. A. (1992) Quantitative in situ hybridization evidence for differential regulation of proenkephalin and dopamine D2 receptor mRNA levels in the rat striatum: effects of unilateral intrastriatal injections of 6-hydroxydopamine.
Brain Res Mol Brain Res, 12: 59-67.
[PMID:1312206]
20. Caine, S. B., Negus, S. S., Mello, N. K., Patel, S., Bristow, L., Kulagowski, J., Vallone, D., Saiardi, A. and Borrelli, E. (2002) Role of dopamine D2-like receptors in cocaine self-administration: studies with D2 receptor mutant mice and novel D2 receptor antagonists.
J Neurosci, 22: 2977-2988.
[PMID:11923462]
21. Calabresi, P., Saiardi, A., Pisani, A., Baik, J. H., Centonze, D., Mercuri, N. B., Bernardi, G. and Borrelli, E. (1997) Abnormal synaptic plasticity in the striatum of mice lacking dopamine D2 receptors.
J Neurosci, 17: 4536-4544.
[PMID:9169514]
22. Castellano, M. A., Liu, L. X., Monsma, F. J., Sibley, D. R., Kapatos, G. and Chiodo, L. A. (1993) Transfected D2 short dopamine receptors inhibit voltage-dependent potassium current in neuroblastoma x glioma hybrid (NG108-15) cells.
Mol Pharmacol, 44: 649-656.
[PMID:8371717]
23. Castelletti, L., Memo, M., Missale, C., Spano, P. F. and Valerio, A. (1989) Potassium channels involved in the transduction mechanism of dopamine D2 receptors in rat lactotrophs.
J Physiol, 410: 251-265.
[PMID:2552081]
24. Chumpradit, S., Kung, M. P., Vessotskie, J., Foulon, C., Mu, M. and Kung, H. F. (1994) Iodinated 2-aminotetralins and 3-amino-1-benzopyrans: ligands for dopamine D2 and D3 receptors.
J Med Chem, 37: 4245-4250.
[PMID:7990123]
25. Cook, C. C. and Gurling, H. M. (1994) The D2 dopamine receptor gene and alcoholism: a genetic effect in the liability for alcoholism.
J R Soc Med, 87: 400-402.
[PMID:8046727]
26. Cunningham, C. L., Howard, M. A., Gill, S. J., Rubinstein, M., Low, M. J. and Grandy, D. K. (2000) Ethanol-conditioned place preference is reduced in dopamine D2 receptor-deficient mice.
Pharmacol Biochem Behav, 67: 693-699.
[PMID:11166059]
27. Dickinson, S. D., Sabeti, J., Larson, G. A., Giardina, K., Rubinstein, M., Kelly, M. A., Grandy, D. K., Low, M. J., Gerhardt, G. A. and Zahniser, N. R. (1999) Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum.
J Neurochem, 72: 148-156.
[PMID:9886065]
28. Fowler, S. C., Zarcone, T. J., Vorontsova, E. and Chen, R. (2002) Motor and associative deficits in D2 dopamine receptor knockout mice.
Int J Dev Neurosci, 20: 309-321.
[PMID:12175868]
29. Freedman, S. B., Patel, S., Marwood, R., Emms, F., Seabrook, G. R., Knowles, M. R. and McAllister, G. (1994) Expression and pharmacological characterization of the human D3 dopamine receptor.
J Pharmacol Exp Ther, 268: 417-426.
[PMID:8301582]
30. Giros, B., Sokoloff, P., Martres, M.-P., Riou, J.-F., Emorine, L. J. and Schwartz, J.-C. (1989) Alternative splicing directs the expression of two D2 dopamine receptor isoforms.
Nature, 342: 923-926.
[PMID:2531847]
31. Grandy, D. K., Marchionni, M. A., Makam, H., Stofko, R. E., Alfano, M., Frothingham, L., Fischer, J. B., Burke-Howie, K. J., Bunzow, J. R. and Server, A. C. (1989) Cloning of the cDNA and gene for a human D2 dopamine receptor.
Proc Natl Acad Sci U S A, 86: 9762-9766.
[PMID:2532362]
32. Jiang, M., Spicher, K., Boulay, G., Wang, Y. and Birnbaumer, L. (2001) Most central nervous system D2 dopamine receptors are coupled to their effectors by Go.
Proc Natl Acad Sci U S A, 98: 3577-3582.
[PMID:11248120]
33. Kelly, M. A., Rubinstein, M., Asa, S. L., Zhang, G., Saez, C., Bunzow, J. R., Allen, R. G., Hnasko, R., Ben-Jonathan, N., Grandy, D. K. and Low, M. J. (1997) Pituitary lactotroph hyperplasia and chronic hyperprolactinemia in dopamine D2 receptor-deficient mice.
Neuron, 19: 103-113.
[PMID:9247267]
34. Kelly, M. A., Rubinstein, M., Phillips, T. J., Lessov, C. N., Burkhart-Kasch, S., Zhang, G., Bunzow, J. R., Fang, Y., Gerhardt, G. A., Grandy, D. K. and Low, M. J. (1998) Locomotor activity in D2 dopamine receptor-deficient mice is determined by gene dosage, genetic background, and developmental adaptations.
J. Neurosci., 18: 3470-3479.
[PMID:9547254]
35. Kita, J. M., Parker, L. E., Phillips, P. E., Garris, P. A. and Wightman, R. M. (2007) Paradoxical modulation of short-term facilitation of dopamine release by dopamine autoreceptors.
J Neurochem, 102: 1115-1124.
[PMID:17663751]
36. Kukreti, R., Tripathi, S., Bhatnagar, P., Gupta, S., Chauhan, C., Kubendran, S., Janardhan Reddy, Y. C., Jain, S. and Brahmachari, S. K. (2006) Association of DRD2 gene variant with schizophrenia.
Neurosci Lett, 392: 68-71.
[PMID:16183199]
37. Köhler, C; Hall, H; Ogren, SO; Gawell, L. (1985) Specific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain.
Biochem. Pharmacol., 34 (13): 2251-9.
[PMID:4015674]
38. L'hirondel, M., Chéramy, A., Godeheu, G., Artaud, F., Saiardi, A., Borrelli, E. and Glowinski, J. (1998) Lack of autoreceptor-mediated inhibitory control of dopamine release in striatal synaptosomes of D2 receptor-deficient mice.
Brain Res, 792: 253-262.
[PMID:9593923]
39. Lajiness, M. E., Chio, C. L. and Huff, R. M. (1993) D2 dopamine receptor stimulation of mitogenesis in transfected Chinese hamster Ovary cells: relationship to dopamine stimulation of tyrosine phosphorylations.
J. Pharmacol. Exp. Ther., 267: 1573-1581.
[PMID:7903393]
40. Liu, Y. F., Civelli, O., Grandy, D. K. and Albert, P. R. (1992) Differential sensitivity of the short and long human dopamine D2 receptor subtypes to protein kinase C.
J Neurochem, 59: 2311-2317.
[PMID:1331329]
41. MacKenzie, R. G., VanLeeuwen, D., Pugsley, T. A., Shih, Y. H., Demattos, S., Tang, L., Todd, R. D. and O'Malley, K. L. (1994) Characterization of the human dopamine D3 receptor expressed in transfected cell lines.
Eur J Pharmacol, 266: 79-85.
[PMID:7907989]
42. Maggio, R., Scarselli, M., Novi, F., Millan, M. J. and Corsini, G. U. (2003) Potent activation of dopamine D3/D2 heterodimers by the antiparkinsonian agents, S32504, pramipexole and ropinirole.
J Neurochem, 87: 631-641.
[PMID:14535946]
43. Malmberg, A., Jackson, D. M., Eriksson, A. and Mohell, N. (1993) Unique binding characteristics of antipsychotic agents interacting with human dopamine D2A, D2B, and D3 receptors.
Mol Pharmacol, 43: 749-754.
[PMID:8099194]
44. Manzanedo, C., Aguilar, M. A., Rodríguez-Arias, M. and Miñarro, J. (2005) Sensitization to the rewarding effects of morphine depends on dopamine.
Neuroreport, 16: 201-205.
[PMID:15671878]
45. McAllister, G., Knowles, M. R., Ward-Booth, S. M., Sinclair, H. A., Patel, S., Marwood, R., Emms, F., Patel, S., Smith, A. and Seabrook, G. R. (1995) Functional coupling of human D2, D3, and D4 dopamine receptors in HEK293 cells.
J Recept Signal Transduct Res, 15: 267-281.
[PMID:8903944]
46. McCall, RB; Lookingland, KJ; Bédard, PJ; Huff, RM. (2005) Sumanirole, a highly dopamine D2-selective receptor agonist: in vitro and in vivo pharmacological characterization and efficacy in animal models of Parkinson's disease.
J. Pharmacol. Exp. Ther., 314 (3): 1248-56.
[PMID:15980060]
47. Mierau, J., Schneider, F. J., Ensinger, H. A., Chio, C. L., Lajiness, M. E. and Huff, R. M. (1995) Pramipexole binding and activation of cloned and expressed dopamine D2, D3 and D4 receptors.
Eur J Pharmacol, 290: 29-36.
[PMID:7664822]
48. Millan, M. J., Maiofiss, L., Cussac, D., Audinot, V., Boutin, J. A. and Newman-Tancredi, A. (2002) Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes.
J Pharmacol Exp Ther, 303: 791-804.
[PMID:12388666]
49. Millan, M. J., Peglion, J. L., Vian, J., Rivet, J. M., Brocco, M., Gobert, A., Newman-Tancredi, A., Dacquet, C., Bervoets, K. and Girardon, S. (1995) Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: 1. Activation of postsynaptic D3 receptors mediates hypothermia, whereas blockade of D2 receptors elicits prolactin secretion and catalepsy.
J Pharmacol Exp Ther, 275: 885-898.
[PMID:7473180]
50. Montmayeur, J. P. and Borrelli, E. (1991) Transcription mediated by a cAMP-responsive promoter element is reduced upon activation of dopamine D2 receptors.
Proc Natl Acad Sci U S A, 88: 3135-3139.
[PMID:1849644]
51. Montmayeur, J. P., Bausero, P., Amlaiky, N., Maroteaux, L., Hen, R. and Borrelli, E. (1991) Differential expression of the mouse D2 dopamine receptor isoforms.
FEBS Lett., 278: 239-243.
[PMID:1991517]
52. Onali, P. and Schwartz, J. P. (1983) Inhibition of VIP-sensitive adenylate cyclase by dopamine in rat anterior pituitary.
Adv. Biochem. Psychopharmacol., 36: 199-207.
[PMID:6344565]
53. Pillai, G., Brown, N. A., McAllister, G., Milligan, G. and Seabrook, G. R. (1998) Human D2 and D4 dopamine receptors couple through betagamma G-protein subunits to inwardly rectifying K+ channels (GIRK1) in a Xenopus oocyte expression system: selective antagonism by L-741,626 and L-745,870 respectively.
Neuropharmacology, 37: 983-987.
[PMID:9833627]
54. Pugsley, T. A., Davis, M. D., Akunne, H. C., MacKenzie, R. G., Shih, Y. H., Damsma, G., Wikstrom, H., Whetzel, S. Z., Georgic, L. M. and Cooke, L. W. (1995) Neurochemical and functional characterization of the preferentially selective dopamine D3 agonist PD 128907.
J Pharmacol Exp Ther, 275: 1355-1366.
[PMID:8531103]
55. Ralph, R. J., Varty, G. B., Kelly, M. A., Wang, Y. M., Caron, M. G., Rubinstein, M., Grandy, D. K., Low, M. J. and Geyer, M. A. (1999) The dopamine D2, but not D3 or D4, receptor subtype is essential for the disruption of prepulse inhibition produced by amphetamine in mice.
J Neurosci, 19: 4627-4633.
[PMID:10341260]
56. Rivet, J. M., Audinot, V., Gobert, A., Peglion, J. L. and Millan, M. J. (1994) Modulation of mesolimbic dopamine release by the selective dopamine D3 receptor antagonist, (+)-S 14297.
Eur J Pharmacol, 265: 175-177.
[PMID:7875234]
57. Rouge-Pont, F., Usiello, A., Benoit-Marand, M., Gonon, F., Piazza, P. V. and Borrelli, E. (2002) Changes in extracellular dopamine induced by morphine and cocaine: crucial control by D2 receptors.
J Neurosci, 22: 3293-3301.
[PMID:11943831]
58. Saiardi, A. and Borrelli, E. (1998) Absence of dopaminergic control on melanotrophs leads to Cushing's-like syndrome in mice.
Mol. Endocrinol., 12: 1133-1139.
[PMID:9717839]
59. Saiardi, A., Bozzi, Y., Baik, J. H. and Borrelli, E. (1997) Antiproliferative role of dopamine: loss of D2 receptors causes hormonal dysfunction and pituitary hyperplasia.
Neuron, 19: 115-126.
[PMID:9247268]
60. Sautel, F., Griffon, N., Lévesque, D., Pilon, C., Schwartz, J. C. and Sokoloff, P. (1995) A functional test identifies dopamine agonists selective for D3versus D2receptors.
Neuroreport, 6: 329-332.
[PMID:7756621]
61. Sautel, F., Griffon, N., Sokoloff, P., Schwartz, J. C., Launay, C., Simon, P., Costentin, J., Schoenfelder, A., Garrido, F., Mann, A. et al.. (1995) Nafadotride, a potent preferential dopamine D3 receptor antagonist, activates locomotion in rodents.
J. Pharmacol. Exp. Ther., 275: 1239-1246.
[PMID:8531087]
62. Schetz, J. A., Benjamin, P. S. and Sibley, D. R. (2000) Nonconserved residues in the second transmembrane-spanning domain of the D(4) dopamine receptor are molecular determinants of D(4)-selective pharmacology.
Mol Pharmacol, 57: 144-152.
[PMID:10617689]
63. Schinelli, S., Paolillo, M. and Corona, G. L. (1994) Opposing actions of D1- and D2-dopamine receptors on arachidonic acid release and cyclic AMP production in striatal neurons.
J Neurochem, 62: 944-949.
[PMID:8113815]
64. Schmitz, Y., Schmauss, C. and Sulzer, D. (2002) Altered dopamine release and uptake kinetics in mice lacking D2 receptors.
J Neurosci, 22: 8002-8009.
[PMID:12223553]
65. Serý, O., Drtílková, I., Theiner, P., Pitelová, R., Staif, R., Znojil, V., Lochman, J. and Didden, W. (2006) Polymorphism of DRD2 gene and ADHD.
Neuro Endocrinol Lett, 27: 236-240.
[PMID:16648784]
66. Setlow, B. and McGaugh, J. L. (2000) D2 dopamine receptor blockade immediately post-training enhances retention in hidden and visible platform versions of the water maze.
Learn Mem, 7: 187-191.
[PMID:10837508]
67. Skaaning Jensen, B., Levavi-Sivan, B., Fishburn, C. S. and Fuchs, S. (1997) Functional expression of the murine D2, D3, and D4 dopamine receptors in Xenopus laevis oocytes.
FEBS Lett, 420: 191-195.
[PMID:9459308]
68. Sokoloff, P., Andrieux, M., Besançon, R., Pilon, C., Martres, M.-P., Giros, B. and Schwartz, J.-C. (1992) Pharmacology of human D3 dopamine receptor expressed in a mammalian cell line : comparison with D2 receptor.
Eur. J. Pharmacol., 225: 331-337.
[PMID:1354163]
69. Sokoloff, P., Giros, B., Martres, M. P., Bouthenet, M. L. and Schwartz, J. C. (1990) Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics.
Nature, 347: 146-151.
[PMID:1975644]
70. Tang, L., Todd, R. D., Heller, A. and O'Malley, K. L. (1994) Pharmacological and functional characterization of D2, D3 and D4 dopamine receptors in fibroblast and dopaminergic cell lines.
J Pharmacol Exp Ther, 268: 495-502.
[PMID:8301592]
71. Tran, A. H., Tamura, R., Uwano, T., Kobayashi, T., Katsuki, M., Matsumoto, G. and Ono, T. (2002) Altered accumbens neural response to prediction of reward associated with place in dopamine D2 receptor knockout mice.
Proc Natl Acad Sci U S A, 99: 8986-8991.
[PMID:12084937]
72. Vukhac, K. L., Sankoorikal, E. B. and Wang, Y. (2001) Dopamine D2L receptor- and age-related reduction in offensive aggression.
Neuroreport, 12: 1035-1038.
[PMID:11303741]
73. Wang, Y., Xu, R., Sasaoka, T., Tonegawa, S., Kung, M. P. and Sankoorikal, E. B. (2000) Dopamine D2 long receptor-deficient mice display alterations in striatum-dependent functions.
J Neurosci, 20: 8305-8314.
[PMID:11069937]
74. Watts, V. J. and Neve, K. A. (1996) Sensitization of endogenous and recombinant adenylate cyclase by activation of D2 dopamine receptors.
Mol Pharmacol, 50: 966-976.
[PMID:8863843]
75. Yamaguchi, H., Aiba, A., Nakamura, K., Nakao, K., Sakagami, H., Goto, K., Kondo, H. and Katsuki, M. (1996) Dopamine D2 receptor plays a critical role in cell proliferation and proopiomelanocortin expression in the pituitary.
Genes Cells, 1: 253-268.
[PMID:9140068]
76. Zhen, J; Antonio, T; Dutta, AK; Reith, ME. (2010) Concentration of receptor and ligand revisited in a modified receptor binding protocol for high-affinity radioligands: [3H]Spiperone binding to D2 and D3 dopamine receptors.
J. Neurosci. Methods, 188 (1): 32-8.
[PMID:20122961]
Annotated and expert reviewed. Please contact us if you can help with updates.
